Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.
Scarcity and a lack of outreach has left millions of immunocompromised Americans without access to the treatment.
The 27-nation bloc is battling with manufacturers over its spot in the priority list for receiving COVID vaccines.
The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.